Biggest Midday Stock Moves: Microsoft, SpaceX And More

I refreshed the tape just after lunch and had to look twice. A software giant was quietly green, a private space name was ripping, a vaccine stock had gone vertical, and Brazilian banks were acting like someone had flipped a switch. You know that feeling when the market is not crashing and not celebrating, yet a handful of names are doing all the talking? That was the session. Midday stock moves like these rarely arrive with a single story. They arrive as a pile of arguments, and the job is to sort which ones still matter after the close.

Perhaps the most interesting aspect is how little these moves had in common on the surface. Chips. A theme-park sphere. A pneumococcal shot. Homebuilders and a rental vehicle. A software buyout. Sports wagering. Beauty. Motorcycles. If you only skimmed the percentage changes, you would miss the thread. Underneath, traders were repricing three things they always reprice when the headlines get loud: who controls scarce capacity, who just got a cleaner earnings path, and who is suddenly tied to a political or regulatory outcome they cannot model in a spreadsheet cell.

What The Midday Tape Was Actually Pricing

A midday print is a rumor with a price attached. It is not a verdict. I have found that the names which hold into the final hour usually had a fundamental hook, not just a hot headline. The ones that fade had excitement and thin liquidity. On this particular afternoon the dispersion was wide enough that both camps were on the screen at once.

Microsoft added a bit more than 1 percent after a research upgrade that leaned hard into security as the next battleground in artificial intelligence. SpaceX jumped about 6 percent after Elon Musk confirmed talks with Taiwan Semiconductor Manufacturing about helping his Terafab chip effort run factories in Texas. TSM itself climbed roughly 2 percent. Intel, also tied to that project, slipped about 2 percent. That split alone is worth sitting with. Same story, opposite reactions.

Elsewhere, Vaxcyte surged around 30 percent on positive late-stage vaccine data. Sphere Entertainment dropped about 12 percent after a downgrade tied to softer demand for a marquee show. Millrose Properties and Lennar each fell near 6 percent after a critical report on rental economics and strategic influence. Brazilian shares went the other way in a hurry.

A single percentage move is a headline. A cluster of related moves is a thesis. The tape on days like this is less a scoreboard than a set of arguments traders are willing to fund before the close.

– Market desk note, paraphrased

Microsoft And The Adult-In-The-Room Trade

The upgrade that lifted Microsoft was not a wild call on cloud growth. It was a governance call. The analyst argued that as security becomes the focal point of enterprise artificial intelligence, Satya Nadella’s team looks increasingly like the group buyers trust when they need cover. The phrase that stuck with me was the idea of an AI CYA trade. Crude, maybe. Also accurate.

Large companies do not adopt models because a demo looked clever. They adopt them when legal, audit, and the chief information security officer can sleep. Microsoft already sits inside identity, endpoint, and productivity workflows. If the next spending cycle is less about raw model bragging rights and more about who can deploy without creating a breach headline, that installed base is not a footnote. It is the product.

A one percent move on a company this size is not small money. It is a repricing of confidence. Still, I would not treat a single upgrade as a new trend. Software multiples have been jumpy whenever bond yields twitch or whenever a rival ships a flashy model. The durable question is simpler. Does security spend travel with AI spend, or does it get postponed when budgets tighten?

• Identity and device control already live inside the same vendor many enterprises use for mail and documents.
• Buyers under regulatory pressure prefer a vendor they can audit, not a stack of startups they have to stitch together.
• The risk is multiple compression if AI revenue shows up slower than the narrative implies.
• The offset is that security budgets are stickier than experimental chatbot budgets.

In my experience, the stocks that win the “trusted operator” frame do not need to be the fastest growers in the group. They need to be the ones procurement will sign when the board asks who is accountable. That is a slower story than a product launch. It can also be a longer one.

SpaceX, TSMC, And A Texas Chip Bet

The chip headline was the one that scrambled more than one ticker. Musk confirmed discussions with TSMC about helping Terafab operate factories in Texas. Intel is part of the same project and still sold off. TSM rose. SpaceX rose more. If you want a clean lesson in how markets assign credit, there it is.

Foundry skill is not a press release. Taiwan Semiconductor has spent decades learning yield, tool uptime, and the boring choreography that turns a wafer into something a customer will pay for. A new venture that wants that help is admitting a basic truth. Building fabs is capital, talent, and process discipline. Talking about building fabs is cheaper.

Why did Intel slip while the others climbed? Traders may be reading participation as dilution of focus, or as a reminder that Intel’s own manufacturing turnaround is still the main event for that stock. A side role in someone else’s Texas plan does not automatically fix server share or foundry credibility. SpaceX, by contrast, gets a narrative extension. Chips for its own stack, political proximity to industrial policy, and a public confirmation that talks are real. Narrative extension is not cash flow. On a midday tape, it still moves price.

I keep coming back to a practical filter. Ask who gets paid if the factories actually run, and who only gets mentioned. TSMC gets paid for process knowledge. A customer gets capacity if the project clears permits, tools, power, and people. Everyone else gets a headline. Headlines are fine. They are not wafers.

Terafab read-through, simplified:
  TSMC  = process partner, credibility bid
  SpaceX = sponsor narrative, larger percentage move
  Intel  = participant, but core story unchanged

Why The Same Chip Story Cut Two Ways

There is a habit on days like this to treat every related ticker as a basket. That habit loses money. Intel and TSMC are not substitutes in a trader’s book just because both words appeared in the same sentence. One is trying to prove it can be a foundry customers trust. The other already is that foundry for a huge share of leading-edge work.

Power, water, and skilled labor in Texas are not abstract risks either. A factory announcement without a staffing plan is a rendering. I have watched enough industrial stories to know the second-year question is always the same. Can you hire the people who keep the tools alive at 2 a.m.? If the answer is fuzzy, the multiple you paid for the dream comes back out of the stock later.

Vaxcyte And A 30 Percent Vaccine Print

Biotech midday moves are a different sport. Vaxcyte jumped about 30 percent after positive topline results from a Phase 3 trial of its pneumococcal conjugate vaccine in adults aged 50 and over. Immune responses were described as comparable to Pfizer’s Prevnar 20 and Merck’s Capvaxive. Comparable is the word that did the work. In vaccines, you do not need to be magic. You need to be close enough that payers and physicians have a reason to switch, or at least a reason not to ignore you.

A 30 percent pop prices a lot of good news at once. Regulatory path. Manufacturing scale. Pricing against incumbents who already own the channel. Adult pneumococcal vaccines are a real market, not a science-fair project, which is why the move was so violent. It is also why the next questions get harder, not easier.

1. Topline immune response is the door, not the room. Label language still has to land.
2. Incumbents will not hand over shelf space because a trial table looked tidy.
3. Capacity and cost of goods decide whether a scientific win becomes a margin win.
4. A stock that gaps 30 percent can give a third of that back on the first cautious note from a reviewer.

I am not a clinician, and I do not pretend midday price action is a peer review. What I will say is that adult vaccine franchises are sticky once a product is in guidelines. Breaking in is the hard part. If the data hold up under a fuller read, this is the kind of result that forces incumbents to talk about share, not just about pipelines. If a subgroup or a safety line disappoints later, the gap becomes a trap for anyone who chased the print.

In vaccines, comparable can be enough. The market, though, often prices comparable as if it already means dominant.

Sphere Entertainment And A Show That Cooled

Sphere Entertainment fell about 12 percent after a broker cut the stock to hold from buy. The concern was specific. Demand for The Wizard of Oz was softening faster than expected, and that could put estimates for the second half of 2026 and the first half of 2027 at risk. Venue stocks live and die on utilization. A spectacular building does not pay the power bill. Repeat attendance does.

Theme and experience names get romantic coverage when a new format opens. Then the calendar shows up. How many nights can you sell a premium ticket before the local audience has seen it, and before tourists treat it as optional? A downgrade that points at a named show is more useful than a vague macro note. It tells you the model was leaning on a title, and the title is cooling.

Does a 12 percent drop overshoot? Maybe, if the next residency or film fills the gap. Maybe not, if the cost base was built for a hotter run-rate. I would watch advance bookings more than the architectural photos. Buildings do not revise guidance. Empty premium seats do.

Millrose, Lennar, And A Rental Critique

Millrose Properties and Lennar each fell roughly 6 percent after a short report questioned the economics of Millrose’s single-family rental investments and raised the issue of Lennar’s potential influence over strategy. I am not going to pretend a short report is a court judgment. Short reports are arguments with a position attached. Some are careful. Some are theater. The price still moved, which means enough holders wanted out before they finished the footnotes.

Single-family rentals became a favorite story when mortgage rates locked owners in place and institutional buyers wanted yield that looked like housing without looking like a REIT cliché. The soft underbelly is always the same. Acquisition basis. Maintenance that does not scale like an apartment corridor. Turnover. And the awkward question of whether a builder’s incentives line up with a landlord’s.

If a builder can move inventory into a related rental vehicle, the optics matter even when the contracts are clean. Buyers of the rental stock want arm’s-length pricing. Buyers of the builder want a release valve for finished homes. Those two wants can coexist. They can also collide the moment someone publishes a model that says the rents do not cover the basis. A 6 percent hit is the market buying time to read, not a final score.

Brazil’s Tape And A Two-Point Election

Then the political print hit, and it dwarfed most of the single-stock noise. Right-wing candidate Flavio Bolsonaro edged incumbent Luiz Inacio Lula da Silva by around two percentage points in Sunday’s election. The iShares MSCI Brazil ETF surged 13 percent. U.S.-listed Itau Unibanco jumped about 16 percent. Banco Bradesco soared about 19 percent. Mercado Libre, which treats Brazil as a core market, advanced 8 percent.

Two points is not a landslide. Markets still treated it like a regime sketch. Banks in particular tend to move first when traders think fiscal tone, credit appetite, or state influence might shift. A 19 percent day in Bradesco is not a statement about next quarter’s net interest margin in any precise sense. It is a statement about the discount rate people were applying to the whole franchise over a weekend.

I get wary when an election gap is this thin and the equity reaction is this fat. Coalitions, courts, and the first hundred days have embarrassed plenty of victory laps. Currency moves can give back a chunk of a bank rally before the ink on cabinet names is dry. Still, ignoring a 13 percent country ETF move because you want more confirmation is its own kind of stubborn. The information arrived. The position size is the only adult decision left.

Mercado Libre’s 8 percent gain is the cleaner read-through for anyone who does not want to underwrite Brazilian bank credit. Commerce and payments in that market swing with confidence, inflation expectations, and the exchange rate. A friendlier policy tape helps. It does not repeal competition or logistics costs. If you own it for Brazil exposure, you just got a gap. If you own it for the rest of the map, Brazil just became a larger slice of the daily P&L whether you asked for that or not.

How Thin Elections Reprice Banks

Bank stocks in emerging markets are leveraged opinions about the sovereign. Not in the cartoon sense that every loan is politics. In the practical sense that funding costs, reserve rules, and the mood of local institutions set the ceiling on returns. A surprise, even a narrow one, compresses or expands that ceiling in a single session.

What I would not do is extrapolate Sunday’s margin into a multi-year earnings model on Monday afternoon. The rally can be right about direction and wrong about magnitude. Bradesco’s 19 percent and Itau’s 16 percent already assume a friendlier backdrop. If the first policy signals are muddled, those gains are inventory, not a floor.

Election gap of ~2 points → country ETF +13% → banks +16% to +19%. Magnitude is the risk, not the direction of the first print.

PTC And A $205 Takeout

PTC surged 33 percent after agreeing to be acquired by Schneider Electric for $205 a share, a deal that values the equity at more than $22 billion. Closing is expected by the third quarter of 2027. That date matters more than the headline percentage. A 2027 close is not next spring. It is a long corridor of regulatory review, integration planning, and the ordinary chance that industrial buyers get picky when their own cycle turns.

Software tucked inside industrial automation is a logical fit on a slide. Design tools, product lifecycle data, and factory software speak to the same customers Schneider already walks the floor with. The premium says the buyer wanted the asset more than the market did yesterday. Arbitrage desks will now care about spread, not about product demos. Everyone else should care about what the price says regarding scarce industrial software.

A deal that far out also leaves a mark on peers. If strategic buyers will pay up for engineering software with sticky workflows, the private-market clearing price just got a public marker. That does not mean every similar name deserves a 33 percent gap. It means the bid is no longer theoretical.

Wells Fargo And A Quieter Upgrade

Wells Fargo gained about 1 percent after an upgrade to overweight from equal weight. The note argued that normalizing balance-sheet growth should ease funding pressure, stabilize net interest margin, and raise conviction in the path to higher returns. Compared with a 30 percent biotech gap, a 1 percent bank move looks sleepy. For a money-center name, it is a real shift in who is willing to own the recovery story.

Funding pressure has been the unglamorous villain of this rate cycle. Deposits got expensive. Wholesale money was not a free substitute. If growth can return without lighting the funding cost on fire again, the margin debate cools. I have found that bank upgrades land better when they talk about the balance sheet than when they talk about a vague efficiency program. You can audit a balance sheet. You cannot audit a slogan.

The leftover risks are the usual ones. Credit if the economy slows. Expenses if technology spend overruns. And the regulatory overhang that never fully leaves a firm with this history. None of that vanished because a note changed a rating. The tape simply agreed, for an afternoon, that the path to better returns looks less blocked.

DraftKings And The Prediction-Market Pitch

DraftKings popped more than 7 percent after an upgrade to buy from neutral. The argument was that prediction markets are a win-win. The note sketched roughly $400 million in fees for 2027, plus $200 million to $400 million from market making. Those are not small numbers next to a business still proving how much sports handle converts into durable profit.

Here is where I get opinionated. Prediction markets sound elegant until you sit with the plumbing. Who is the customer? A sports bettor looking for a new contract, or a news junkie who vanishes after election week? Fees on flow are wonderful if the flow is habitual. Market-making income is wonderful until the book is wrong-footed on a gap event and the “win-win” has a bad Tuesday.

Regulation is the other hinge. A product that lives in a gray zone can be a growth story on Monday and a legal memo on Friday. I do not need the category to fail for the stock to be mispriced. I need the 2027 fee number to slip, or the market-making range to be the optimistic edge of the range. A 7 percent move says traders wanted exposure to that optionality today. It does not say the option is in the money.

• Fee income needs repeat users, not a single noisy news cycle.
• Market making adds earnings power and earnings volatility in the same package.
• State and federal rules can redraw the addressable market without a product failing.
• Sports handle remains the core engine. New verticals are additive until they are not.

Estee Lauder And A Multi-Year Beauty Call

Estee Lauder rose about 2 percent after an upgrade to overweight from equal weight. The bank said it is bullish on the growth and earnings profile over the next several years. Beauty is a strange category for a midday tape because the drivers are slow. Travel retail. China sell-through. Inventory sitting with retailers. Brand heat that you cannot fake with a quarter of promotions.

A 2 percent move is the market nodding, not sprinting. That feels right. If the call is about several years, the stock should not need to gap like a biotech readout. What would change my mind is evidence that channel inventory is clean and that full-price sell-through is doing the work, not discounting. Prestige cosmetics can look healthy on shipments and sick on the shelf. I have watched that movie.

The upgrade is a reminder that not every interesting afternoon story is a technology story. Consumer names still reprice when someone with a model decides the trough is behind them. Whether the trough is actually behind them is a store-check question, not a rating question.

Harley-Davidson And A Product-Cycle Bid

Harley-Davidson rose about 10 percent after an upgrade to buy from neutral. The shift in tone was from a modest retail improvement earlier in the year toward a belief that a major product introduction, cost savings, and possible earnings help from LiveWire can matter. Ten percent is a lot for a manufacturer on an upgrade alone. It tells you positioning was light and the note gave shorts a reason to cover.

Motorcycle demand is cyclical, demographic, and oddly emotional. A new platform can pull forward buyers who have been waiting. It can also disappoint if the price point misses the rider who actually shows up at the dealer. Cost savings are more bankable than product hope, right up until they collide with warranty expense. LiveWire remains the optional swing factor. Useful if it contributes. Not the reason to own the equity if the core bike business is soft.

I would rather see dealer inventories and financing terms than another slogan about heritage. Heritage does not move metal when monthly payments do. If the product introduction is real and the cost line is real, the 10 percent can stick. If it was a cover bid, you will know within a couple of sessions.

Reading Dispersion Without Losing The Plot

Put the session on one page and the pattern is dispersion, not direction. Mega-cap software firmed on a trust narrative. A space-and-chips complex split three ways. A vaccine name revalued a franchise in an hour. An experience stock got marked down for a cooling show. Housing-related names absorbed a critical report. Brazil repriced a government. A software takeout printed a number. A money-center bank, a betting firm, a beauty house, and a motorcycle maker each got their own note.

That is a lot of information. It is also a trap if you treat every green print as confirmation of a personal thesis. Midday stock moves are invitations to do the work, not substitutes for it. The questions that survive the close are boring on purpose.

1. Is the new information about cash flow, or about a story people enjoy?
2. Who is on the other side of the trade, and were they forced?
3. Does the move change estimates, or only the multiple for a week?
4. What would falsify the headline before the next earnings call?

Microsoft’s security angle can be falsified if enterprise buyers keep piloting models without expanding identity and compliance spend. The Terafab talks can be falsified by silence on tools and power. Vaxcyte’s gap can be falsified by a fuller data cut. Sphere can be falsified, in the other direction, by a new title that refills the calendar. Brazil can be falsified by policy that looks like the old mix with a new spokesman. PTC’s deal can be falsified by a review that drags or a spread that blows out. None of those checks require a hot take. They require a calendar.

Position Size Beats Hot Certainty

A habit I trust more than any afternoon note is sizing. A 30 percent biotech move and a 1 percent software move do not deserve the same emotional volume in a portfolio conversation. The biotech move changed the market value of a pipeline outcome. The software move nudged a giant. Both can be “right” and still demand different risk. If your book treats them as equal signals, the book is the problem, not the tape.

Brazil is the clearest example. A 13 percent country ETF day is either a gift or a gap you are now underwriting. Chasing it because the screens are green is not a macro view. It is adrenaline. Waiting for a perfect policy blueprint is also a choice, and it has a cost if the currency follows the equity. There is no clean answer in the first session. There is only a size you can live with if the two-point margin produces a messy coalition.

Same rule for DraftKings. Optionality on prediction markets is worth something. It is not worth forgetting that market-making losses show up faster than fee dreams. Same rule for Harley. A product cycle is worth something. It is not worth ignoring payment sensitivity. The midday print is the start of that argument.

What I Would Watch Into The Close And After

Into the close, I watch whether the extreme moves keep their gains on rising volume or leak once the headline readers are done. Vaxcyte, Bradesco, PTC, and Sphere are the tells. Microsoft and Wells Fargo should be dull if the session is healthy. Dull is fine. Dull means the upgrade was absorbed rather than chased.

After the close, the useful work is narrower than people think. Read the vaccine topline with a skeptical eye on endpoints, not on the percentage gap. Read the Brazil result as a margin, not a mandate. Read the Terafab comment as a discussion, not a fab. Read the rental critique as a claim that needs rent rolls and related-party terms, not as a conclusion. Read the PTC price as a marker for industrial software scarcity, with a 2027 clock attached.

If that sounds unglamorous, good. The glamorous version of this session is a list of winners. The useful version is a list of claims. Markets pay you, occasionally, for telling those apart before the next person does.

A Desk Checklist For Sessions Like This

When the board looks like a variety show, I fall back on a short checklist. It is not clever. It keeps me from narrating every tick.

• Separate event moves from estimate moves. An election and a Phase 3 table are events. A bank upgrade is an estimate nudge.
• Check whether peers confirmed the move. TSM up and Intel down means the chip story was not a single trade.
• Note the time horizon buried in the headline. PTC’s close target sits in 2027. Sphere’s risk window was flagged through early 2027. DraftKings’ fee sketch pointed at 2027. Those are not this quarter.
• Ask what a reversal would look like. For Brazil, a currency giveback. For Vaxcyte, a data nit. For Sphere, a booking update. For Harley, a dealer check that contradicts the note.
• Write down what you will not do. I will not treat a short report as audited fact. I will not treat a confirmed discussion as a finished factory.

That last line is the one I break most often when I am tired. Confirmed discussions feel like progress because someone important said them out loud. Factories are progress when the tools are installed. The distance between those two sentences is where a lot of afternoon gains go to retire.

Sector By Sector, Without The Noise

Technology today was not one sector. It was security software, foundry politics, and an industrial software bid. Microsoft’s edge, if the upgrade is right, is distribution plus accountability. TSMC’s edge is process. PTC’s edge, from the buyer’s side, is workflow data Schneider can cross-sell. Lumping those into “tech was up” would be lazy. One firm gained a point. Another agreed to sell itself. A third talked about helping run someone else’s plant.

Health care was a single name doing the heavy lifting. A comparable immune response in older adults is commercially legible, which is why the stock did not need a translator. The rest of the group did not have to participate for the signal to count. That is typical of binary data. It concentrates.

Financials split by geography. Wells Fargo inched up on a domestic funding story. Brazilian banks leaped on a political story. Same sector label, unrelated engines. If your screen groups them, your risk system should not.

Consumer and leisure were a grab bag. Sphere down on a show. Estee Lauder up on a multi-year earnings hope. Harley up on product and cost. DraftKings up on a new contract type. Anyone forcing a consumer narrative across that set is storytelling. The better read is idiosyncratic catalysts landing on the same afternoon.

The Housing Angle Nobody Wanted

Millrose and Lennar deserve a second pass because housing narratives have been crowded. Builders have been treated as rate bets. Rental vehicles have been treated as yield bets. A critique that questions basis and influence attacks both costumes at once. Even if you dismiss the report, the 6 percent move says some holders did not want to explain the structure on a Monday call.

Related-party questions linger longer than product questions. A bike launch can be checked at a dealer in a month. A vaccine table can be checked when the appendix drops. A web of investments between a builder and a rental owner takes documents, and documents take time. Until that time passes, the multiple carries a haircut. That haircut can be unfair. Unfair haircuts still change returns.

I do not have a strong view on the specific economics from a single afternoon. I do have a view on process. If you own either name, read the transaction terms before you read the rebuttal. Rebuttals are written fast. Terms were written by lawyers.

Industrial Software Just Got A Public Price

The PTC agreement is easy to file under “deal news” and move on. I would not. A price above $22 billion in equity value, at $205 a share, from a strategic buyer, is a data point for every firm that sells design, simulation, or lifecycle tools into factories. Strategic buyers pay for revenue they think they can attach to hardware and service contracts. Financial buyers pay for cash flow they can lever. This was the first kind.

The 2027 close is the sober half of the headline. A lot of industrial cycles can turn before then. A lot of software retention can be tested before then. The spread will tell you what arbitrage thinks of completion risk. The peer stocks will tell you what long-only thinks the bid implies. Those two messages can disagree, and when they do, the disagreement is the trade.

A Word On Chasing Percentage Theater

Thirty percent. Nineteen percent. Thirteen percent. Twelve percent down. Ten percent. The eye goes to the extremes. That is human, and it is how people buy the high of a headline. Percentage theater is not analysis. Bradesco moving 19 percent on an election is a different animal from Vaxcyte moving 30 percent on immune-response data. One is a discount-rate shock. The other is a probability shock on a product. Mixing them into a “winners list” flatters the writer and confuses the reader.

If I had to rank what might still matter in a month, I would put the vaccine data, the Brazil margin, and the PTC price ahead of the upgrade cluster. Upgrades explain an afternoon. Data and deals explain a supply-demand change. Elections explain a risk premium until policy shows its hand. Your ranking can differ. The act of ranking is the point. A flat list of movers is a news recap. A ranked list is a portfolio.

The useful question after a wild midday is not who moved. It is which move changed the facts you will still care about on the next earnings date.

Putting A Notebook Around The Session

Here is the notebook version I would actually keep. Microsoft: security and governance as the AI spending filter, small gain, large market value. SpaceX and TSMC: talks about Texas factory help, credibility flowing to the foundry incumbent and the sponsor, not automatically to Intel. Vaxcyte: adult pneumococcal data called comparable to two incumbent products, huge gap, proof still ahead on label and launch. Sphere: show demand cooling faster than a prior model assumed. Millrose and Lennar: rental economics and influence under attack, price lower while documents get read. Brazil complex: narrow election lead, violent rally in the country ETF, Itau, Bradesco, and a solid Mercado Libre bid. PTC: agreed sale at $205, long close. Wells Fargo: funding and margin path looks cleaner to at least one desk. DraftKings: prediction-market fees and market making sketched as a 2027 earnings bridge. Estee Lauder: multi-year earnings hope, modest move. Harley-Davidson: product, costs, LiveWire optionality, sharp cover-friendly jump.

None of that requires a heroic macro call. The index can finish flat while this list still describes a busy day. That is the modern tape. Breadth can be ordinary. Single-name variance can be the whole story. If you only watch the index, you missed the argument. If you only watch the loudest percentage, you missed the split inside the chip complex and the difference between a one-point bank upgrade and a nineteen-point election trade.

I will leave it there, with one bias stated plainly. I trust moves that come with a document more than moves that come with an adjective. A trial table, a merger agreement, an election tally, a downgrade that names a show. Adjectives like transformative and win-win can wait until the cash shows up. The midday tape offered both kinds of evidence. Sorting them is the work. The percentages were just the knock on the door.